Login to Your Account



Serono Enlists Marketing Muscle' Of Pfizer In $200M Rebif Alliance

By Karen Young


Friday, July 12, 2002
Serono SA is teaming up with Pfizer Inc. to co-promote the multiple sclerosis drug Rebif in the United States, which will position Rebif directly against Biogen Inc.'s powerhouse drug Avonex. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription